News & Events

February 28, 2022

The Israeli Company That Develops Treatment for Rare Diseases [Hebrew article] Download this news article Read More Read More

Minovia to Present at Piper Sandler Healthcare Conference for Private Companies on November 29, 2021 Download this news article Read More Read More

September 24, 2021

Minovia’s Preclinical Publication in Nature’s Journal of Regenerative Medicine on the Benefit Conferred by Mitochondrially-augmenetd CD34+ Cells in Patients with Mitochondrial Disorders Download this news article Read More Read More

July 30, 2021

Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs Read More Read More

April 27-29, 2021

Minovia Therapeutics’ CEO Natalie Yivgi-Ohana to present at the Mitochondria-Targeted Drug Development Conference April 27-29, 2021 Read More Read More

March 12, 2021

Minovia Therapeutics Announces Appointment of Alan Jacobs, MSEE, MD, PhD as Chief Medical Officer Download this news article Read More Read More

November 23, 2020

Minovia Therapeutics Announces Manufacturing Partnership with BioSpherix and Appoints David O’Donnell as Global Head of Manufacturing and Supply Chain Download this news article Read More

November 9, 2020

Minovia Therapeutics to Participate at Upcoming Credit Suisse Healthcare Conference on November 12th Read More Read More

June 26, 2019

Minovia Therapeutics Announces Dosing of Patient in First Mitochondrial Cell Therapy Trial for the Treatment of Pearson Syndrome & Names John Cox as Executive Chairman Download this news article Read More Read More